Страна: Австралия
Язык: английский
Источник: Department of Health (Therapeutic Goods Administration)
hyoscine butylbromide, Quantity: 20 mg/mL
Medsurge Pharma Pty Ltd
Injection, solution
Excipient Ingredients: water for injections; hydrochloric acid; sodium chloride; sodium hydroxide
Intravenous, Intramuscular
5 x 20 mg/1 mL, 10 x 20 mg/1 mL
(S4) Prescription Only Medicine
Spasm of the gastrointestinal tract, biliary spasm, renal spasm, diagnostic aid in radiology.
Visual Identification: Hyoscine Butylbromide injection is a clear colourless or almost colourless solution.; Container Type: Ampoule; Container Material: Glass Type I Clear; Container Life Time: 5 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert
Registered
2020-09-29